Luis Fein

Researcher Next ID · RN-010396

Researcher · Medicine

, Argentina

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Cancer Treatment and Pharmacology

HER2/EGFR in Cancer Research

Radiopharmaceutical Chemistry and Applications

Breast Cancer Treatment Studies

Colorectal Cancer Treatments and Studies

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
The Lancet · 2019 · 10.1016/s0140-6736(18)32409-7
Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial
The Lancet Oncology · 2019 · 10.1016/s1470-2045(19)30082-8
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
New England Journal of Medicine · 2017 · 10.1056/nejmoa1704174
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
The Lancet · 2015 · 10.1016/s0140-6736(15)00986-1
Double-Blind, Randomized Placebo Controlled Trial of Fulvestrant Compared With Exemestane After Prior Nonsteroidal Aromatase Inhibitor Therapy in Postmenopausal Women With Hormone Receptor–Positive, Advanced Breast Cancer: Results From EFECT
Journal of Clinical Oncology · 2008 · 10.1200/jco.2007.13.5822

No projects listed.